Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
暂无分享,去创建一个
[1] J. Garber,et al. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. , 2000, JAMA.
[2] S. Cummings,et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. , 1999, JAMA.
[3] M. Cho,et al. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test. , 1999, American journal of medical genetics.
[4] D J Schaid,et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.
[5] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[6] A. Mes-Masson,et al. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. , 1998, American journal of human genetics.
[7] D. Berry,et al. Testing for the BRCA1 and BRCA2 Breast-Ovarian Cancer Susceptibility Genes , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] B. Ponder,et al. Oral Contraceptives and the Risk of Hereditary Ovarian Cancer , 1998 .
[9] S. Cummings,et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. King,et al. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. , 1998, JAMA.
[11] J. Thompson,et al. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. , 1998, JAMA.
[12] A. Neugut,et al. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[14] B. Rimer,et al. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] K Offit,et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. , 1997, JAMA.
[16] W. Neufeld-Kaiser,et al. Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors. , 1997, JAMA.
[17] H. Lynch,et al. Cancer risk assessment in a hereditary cancer prevention clinic and its first year's experience , 1997 .
[18] K M Kuntz,et al. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. , 1997, The New England journal of medicine.
[19] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[20] B. Wilfond,et al. Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent , 1997 .
[21] J. Eyfjörd,et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. , 1997, American journal of human genetics.
[22] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .
[23] G. Petersen,et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. , 1997, The New England journal of medicine.
[24] A S Whittemore,et al. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. , 1997, American journal of human genetics.
[25] B. Rimer,et al. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. , 1997, American journal of medical genetics.
[26] Should we test women for inherited susceptibility to breast cancer? what do NC primary care physicians think. , 1997, North Carolina medical journal.
[27] J. E. Nash,et al. Psychological responses to BRCA1 mutation testing: preliminary findings. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[28] A. Ganguly,et al. Detection of mutations in multi‐exon genes: Comparison of conformation sensitive gel electrophoresis and sequencing strategies with respect to cost and time for finding mutations , 1997, Human mutation.
[29] Alfred A. Boyd,et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.
[30] B. Trock,et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.
[31] W. Thompson,et al. The genetic attributable risk of breast and ovarian cancer , 1996, Cancer.
[32] D. Bentley,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.
[33] W J Hall,et al. Women's receptivity to testing for a genetic susceptibility to breast cancer. , 1995, American journal of public health.
[34] M. Seller,et al. Unusual case of Smith-Lemli-Opitz syndrome "type II". , 1995, American journal of medical genetics.
[35] B. Rimer,et al. Effects of individualized breast cancer risk counseling: a randomized trial. , 1995, Journal of the National Cancer Institute.
[36] M. Stefanek. Bilateral prophylactic mastectomy: issues and concerns. , 1995, Journal of the National Cancer Institute. Monographs.
[37] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[38] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[39] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[40] M. Thun,et al. Family history, age, and risk of fatal breast cancer. , 1993, American journal of epidemiology.
[41] J. Manson,et al. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. , 1993, JAMA.
[42] P. Engstrom,et al. Mammography adherence and psychological distress among women at risk for breast cancer. , 1993, Journal of the National Cancer Institute.
[43] J. Holland,et al. Psychological distress and surveillance behaviors of women with a family history of breast cancer. , 1992, Journal of the National Cancer Institute.